Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Stefan Aebi Swiss Group for Clinical Cancer Research Urban Novak (physician) |
| Publication date | April 13, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |